Richard Knox

Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.

Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.

Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.

He and his wife Jean, an editor, live in Boston. They have two daughters.

Pages

Shots - Health Blog
2:51 pm
Wed December 7, 2011

Why Observing Prostate Cancers Is Gaining Ground On Surgery

Originally published on Wed December 7, 2011 3:26 pm

A federally convened panel of experts says most men with newly diagnosed prostate cancer should be offered the chance to put off treatment in favor of medical monitoring of their condition.

In fact, the panel went so far as to say doctors should stop calling most of these low-risk tumors cancer at all.

Read more
Shots - Health Blog
3:33 pm
Fri December 2, 2011

US AIDS Chief Says Tipping Point Is In Sight

Eric Goosby, United States Global AIDS Coordinator, sees a turning point for HIV coming soon.
Brendan Hoffman Getty Images

Originally published on Fri December 2, 2011 3:51 pm

If all goes according to plan — the plan President Obama laid out on Thursday — the HIV pandemic may reach an important tipping point by the end of 2013.

"We believe that with 2 million more people in treatment, we will reach a point where the number of new infections is less than the number going into treatment," says Dr. Eric Goosby.

Read more

Pages